315 related articles for article (PubMed ID: 30269440)
1. Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis.
Dhillon AK; Kummen M; Trøseid M; Åkra S; Liaskou E; Moum B; Vesterhus M; Karlsen TH; Seljeflot I; Hov JR
Liver Int; 2019 Feb; 39(2):371-381. PubMed ID: 30269440
[TBL] [Abstract][Full Text] [Related]
2. Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis.
Tornai T; Palyu E; Vitalis Z; Tornai I; Tornai D; Antal-Szalmas P; Norman GL; Shums Z; Veres G; Dezsofi A; Par G; Par A; Orosz P; Szalay F; Lakatos PL; Papp M
World J Gastroenterol; 2017 Aug; 23(29):5412-5421. PubMed ID: 28839442
[TBL] [Abstract][Full Text] [Related]
3. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.
Vesterhus M; Holm A; Hov JR; Nygård S; Schrumpf E; Melum E; Thorbjørnsen LW; Paulsen V; Lundin K; Dale I; Gilja OH; Zweers SJLB; Vatn M; Schaap FG; Jansen PLM; Ueland T; Røsjø H; Moum B; Ponsioen CY; Boberg KM; Färkkilä M; Karlsen TH; Lund-Johansen F
J Hepatol; 2017 Jun; 66(6):1214-1222. PubMed ID: 28161472
[TBL] [Abstract][Full Text] [Related]
4. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease.
Lakatos PL; Kiss LS; Palatka K; Altorjay I; Antal-Szalmas P; Palyu E; Udvardy M; Molnar T; Farkas K; Veres G; Harsfalvi J; Papp J; Papp M
Inflamm Bowel Dis; 2011 Mar; 17(3):767-77. PubMed ID: 20865702
[TBL] [Abstract][Full Text] [Related]
5. Secondary Sclerosing Cholangitis in Critically Ill Patients Alters the Gut-Liver Axis: A Case Control Study.
Blesl A; Jüngst C; Lammert F; Fauler G; Rainer F; Leber B; Feldbacher N; Stromberger S; Wildburger R; Spindelböck W; Fickert P; Horvath A; Stadlbauer V
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32906634
[TBL] [Abstract][Full Text] [Related]
6. Effects of dietary intervention and n-3 PUFA supplementation on markers of gut-related inflammation and their association with cardiovascular events in a high-risk population.
Awoyemi A; Trøseid M; Arnesen H; Solheim S; Seljeflot I
Atherosclerosis; 2019 Jul; 286():53-59. PubMed ID: 31100620
[TBL] [Abstract][Full Text] [Related]
7. CD14 is associated with biliary stricture formation.
Friedrich K; Smit M; Brune M; Giese T; Rupp C; Wannhoff A; Kloeters P; Leopold Y; Denk GU; Weiss KH; Stremmel W; Sauer P; Hohenester S; Schirmacher P; Schemmer P; Gotthardt DN
Hepatology; 2016 Sep; 64(3):843-52. PubMed ID: 26970220
[TBL] [Abstract][Full Text] [Related]
8. Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease.
Pastor Rojo O; López San Román A; Albéniz Arbizu E; de la Hera Martínez A; Ripoll Sevillano E; Albillos Martínez A
Inflamm Bowel Dis; 2007 Mar; 13(3):269-77. PubMed ID: 17206721
[TBL] [Abstract][Full Text] [Related]
9. Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis.
Bossen L; Vesterhus M; Hov JR; Färkkilä M; Rosenberg WM; Møller HJ; Boberg KM; Karlsen TH; Grønbæk H
Clin Transl Gastroenterol; 2021 Mar; 12(3):e00315. PubMed ID: 33646203
[TBL] [Abstract][Full Text] [Related]
10. Serum Lipopolysaccharide-Binding Protein is Associated with Chronic Inflammation and Metabolic Syndrome in Hemodialysis Patients.
Lim PS; Chang YK; Wu TK
Blood Purif; 2019; 47(1-3):28-36. PubMed ID: 30219816
[TBL] [Abstract][Full Text] [Related]
11. Serological markers of extracellular matrix remodeling predict transplant-free survival in primary sclerosing cholangitis.
Nielsen MJ; Thorburn D; Leeming DJ; Hov JR; Nygård S; Moum B; Saffioti F; Gilja OH; Boberg KM; Mazza G; Røsjø H; Pinzani M; Karlsen TH; Karsdal MA; Vesterhus M
Aliment Pharmacol Ther; 2018 Jul; 48(2):179-189. PubMed ID: 29851098
[TBL] [Abstract][Full Text] [Related]
12. Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia.
Severance EG; Gressitt KL; Stallings CR; Origoni AE; Khushalani S; Leweke FM; Dickerson FB; Yolken RH
Schizophr Res; 2013 Aug; 148(1-3):130-7. PubMed ID: 23746484
[TBL] [Abstract][Full Text] [Related]
13. Increased intestinal permeability in patients with short bowel syndrome is not affected by parenteral nutrition.
Cinkajzlová A; Lacinová Z; Kloučková J; Kaválková P; Kratochvílová H; Křížová J; Trachta P; Mráz M; Haluzík M
Physiol Res; 2019 Oct; 68(5):817-825. PubMed ID: 31424246
[TBL] [Abstract][Full Text] [Related]
14. Obesity and polycystic ovary syndrome influence on intestinal permeability at fasting, and modify the effect of diverse macronutrients on the gut barrier.
Martínez-García MÁ; Quintero-Tobar A; de Lope Quiñones S; Insenser M; Fernández-Durán E; Escobar-Morreale HF; Luque-Ramírez M
Food Res Int; 2024 Jun; 186():114338. PubMed ID: 38729719
[TBL] [Abstract][Full Text] [Related]
15. Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.
de Vries EMG; Färkkilä M; Milkiewicz P; Hov JR; Eksteen B; Thorburn D; Chazouillères O; Pares A; Nygård S; Gilja OH; Wunsch E; Invernizzi P; Carbone M; Bernuzzi F; Boberg KM; Røsjø H; Rosenberg W; Beuers UH; Ponsioen CY; Karlsen TH; Vesterhus M
Liver Int; 2017 Oct; 37(10):1554-1561. PubMed ID: 28267887
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide binding protein and sCD14 as risk markers of stroke-associated pneumonia.
Gradek-Kwinta E; Czyzycki M; Lopatkiewicz AM; Klimiec-Moskal E; Slowik A; Dziedzic T
J Neuroimmunol; 2021 May; 354():577532. PubMed ID: 33676085
[TBL] [Abstract][Full Text] [Related]
17. Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis.
Hilscher M; Enders FB; Carey EJ; Lindor KD; Tabibian JH
Ann Hepatol; 2016; 15(2):246-53. PubMed ID: 26845602
[TBL] [Abstract][Full Text] [Related]
18. Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis.
Kirstein MM; Book T; Manns MP; von Hahn T; Voigtländer T
United European Gastroenterol J; 2020 Jul; 8(6):716-724. PubMed ID: 32366182
[TBL] [Abstract][Full Text] [Related]
19. No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan.
Tanaka A; Tazuma S; Nakazawa T; Isayama H; Tsuyuguchi T; Inui K; Takikawa H
J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):217-225. PubMed ID: 28103424
[TBL] [Abstract][Full Text] [Related]
20. Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis.
Umemura T; Sekiguchi T; Joshita S; Yamazaki T; Fujimori N; Shibata S; Ichikawa Y; Komatsu M; Matsumoto A; Shums Z; Norman GL; Tanaka E; Ota M
Liver Int; 2017 Jun; 37(6):897-905. PubMed ID: 27860118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
